4.6 Article Proceedings Paper

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Features and potentials of ATP-site directed CK2 inhibitors

S Sarno et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)